Listed

Zomedica Corp.

ZOMDFOTCCIK 1684144HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Revenue$9.5m, Q2 FY2026
Operating income−$4.1m, Q2 FY2026
Net income−$3.8m, Q2 FY2026
Zomedica Corp., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Revenue$m6.3Revenue, Q3 FY2023, three months to 2023-09-30$6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure7.3Revenue, Q4 FY2023, three months to 2023-12-31$7.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-13, accession 0001558370-25-002904. Derived: 12-month figure less the 9-month figure.Report this figure6.3Revenue, Q1 FY2024, three months to 2024-03-31$6.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure6.1Revenue, Q2 FY2024, three months to 2024-06-30$6.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure7.0Revenue, Q3 FY2024, three months to 2024-09-30$7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure7.9Revenue, Q4 FY2024, three months to 2024-12-31$7.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure6.5Revenue, Q1 FY2025, three months to 2025-03-31$6.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure7.0Revenue, Q2 FY2025, three months to 2025-06-30$7.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure8.1Revenue, Q3 FY2025, three months to 2025-09-30$8.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure10.5Revenue, Q4 FY2025, three months to 2025-12-31$10.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure8.8Revenue, Q1 FY2026, three months to 2026-03-31$8.8m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure9.5Revenue, Q2 FY2026, three months to 2026-06-30$9.5m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Cost of revenue$m2.0Cost of revenue, Q3 FY2023, three months to 2023-09-30$2.0m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure2.3Cost of revenue, Q4 FY2023, three months to 2023-12-31$2.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2025-03-13, accession 0001558370-25-002904. Derived: 12-month figure less the 9-month figure.Report this figure2.1Cost of revenue, Q1 FY2024, three months to 2024-03-31$2.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure1.8Cost of revenue, Q2 FY2024, three months to 2024-06-30$1.8m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure1.9Cost of revenue, Q3 FY2024, three months to 2024-09-30$1.9m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure2.3Cost of revenue, Q4 FY2024, three months to 2024-12-31$2.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure2.1Cost of revenue, Q1 FY2025, three months to 2025-03-31$2.1m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure2.3Cost of revenue, Q2 FY2025, three months to 2025-06-30$2.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure2.7Cost of revenue, Q3 FY2025, three months to 2025-09-30$2.7m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure3.3Cost of revenue, Q4 FY2025, three months to 2025-12-31$3.3m. XBRL concept us-gaap:CostOfRevenue. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure3.3Cost of revenue, Q1 FY2026, three months to 2026-03-31$3.3m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure3.5Cost of revenue, Q2 FY2026, three months to 2026-06-30$3.5m. XBRL concept us-gaap:CostOfRevenue. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Gross profit$m4.4Gross profit, Q3 FY2023, three months to 2023-09-30$4.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure5.1Gross profit, Q4 FY2023, three months to 2023-12-31$5.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-13, accession 0001558370-25-002904. Derived: 12-month figure less the 9-month figure.Report this figure4.1Gross profit, Q1 FY2024, three months to 2024-03-31$4.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure4.4Gross profit, Q2 FY2024, three months to 2024-06-30$4.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure5.1Gross profit, Q3 FY2024, three months to 2024-09-30$5.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure5.5Gross profit, Q4 FY2024, three months to 2024-12-31$5.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure4.4Gross profit, Q1 FY2025, three months to 2025-03-31$4.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure4.7Gross profit, Q2 FY2025, three months to 2025-06-30$4.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure5.4Gross profit, Q3 FY2025, three months to 2025-09-30$5.4m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure7.2Gross profit, Q4 FY2025, three months to 2025-12-31$7.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure5.5Gross profit, Q1 FY2026, three months to 2026-03-31$5.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure6.0Gross profit, Q2 FY2026, three months to 2026-06-30$6.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Research and development$m0.9Research and development, Q3 FY2023, three months to 2023-09-30$867.0k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure3.1Research and development, Q4 FY2023, three months to 2023-12-31$3.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2025-03-13, accession 0001558370-25-002904. Derived: 12-month figure less the 9-month figure.Report this figure1.8Research and development, Q1 FY2024, three months to 2024-03-31$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure1.5Research and development, Q2 FY2024, three months to 2024-06-30$1.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure1.8Research and development, Q3 FY2024, three months to 2024-09-30$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure2.1Research and development, Q4 FY2024, three months to 2024-12-31$2.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure1.9Research and development, Q1 FY2025, three months to 2025-03-31$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure1.9Research and development, Q2 FY2025, three months to 2025-06-30$1.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure1.8Research and development, Q3 FY2025, three months to 2025-09-30$1.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure1.6Research and development, Q4 FY2025, three months to 2025-12-31$1.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure1.2Research and development, Q1 FY2026, three months to 2026-03-31$1.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure1.1Research and development, Q2 FY2026, three months to 2026-06-30$1.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Selling, general and administrative$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Operating income$m(5.9)Operating income, Q3 FY2023, three months to 2023-09-30−$5.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure(23.1)Operating income, Q4 FY2023, three months to 2023-12-31−$23.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-13, accession 0001558370-25-002904. Derived: 12-month figure less the 9-month figure.Report this figure(10.4)Operating income, Q1 FY2024, three months to 2024-03-31−$10.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure(25.1)Operating income, Q2 FY2024, three months to 2024-06-30−$25.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure(7.4)Operating income, Q3 FY2024, three months to 2024-09-30−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure(8.2)Operating income, Q4 FY2024, three months to 2024-12-31−$8.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure(64.5)Operating income, Q1 FY2025, three months to 2025-03-31−$64.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure(8.0)Operating income, Q2 FY2025, three months to 2025-06-30−$8.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure(6.6)Operating income, Q3 FY2025, three months to 2025-09-30−$6.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure(5.2)Operating income, Q4 FY2025, three months to 2025-12-31−$5.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure(4.9)Operating income, Q1 FY2026, three months to 2026-03-31−$4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure(4.1)Operating income, Q2 FY2026, three months to 2026-06-30−$4.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Interest expense$m0.1Interest expense, Q3 FY2023, three months to 2023-09-30$64.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2023-11-13, accession 0001558370-23-018830.Report this figure(0.1)Interest expense, Q4 FY2023, three months to 2023-12-31−$125.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2024-05-09, accession 0001558370-24-007597. Derived: 12-month figure less the 9-month figure.Report this figurenot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Income tax$m(1.9)Income tax, Q3 FY2023, three months to 2023-09-30−$1.9m. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure0.5Income tax, Q4 FY2023, three months to 2023-12-31$459.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2025-03-13, accession 0001558370-25-002904. Derived: 12-month figure less the 9-month figure.Report this figure(0.2)Income tax, Q1 FY2024, three months to 2024-03-31−$166.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure(0.1)Income tax, Q2 FY2024, three months to 2024-06-30−$143.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure(0.0)Income tax, Q3 FY2024, three months to 2024-09-30−$27.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure(0.2)Income tax, Q4 FY2024, three months to 2024-12-31−$221.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure(0.1)Income tax, Q1 FY2025, three months to 2025-03-31−$57.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure0.0Income tax, Q2 FY2025, three months to 2025-06-30$12.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure(0.0)Income tax, Q3 FY2025, three months to 2025-09-30−$19.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure(0.2)Income tax, Q4 FY2025, three months to 2025-12-31−$214.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$39.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$26.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Net income$m(0.5)Net income, Q3 FY2023, three months to 2023-09-30−$491.0k. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure(22.4)Net income, Q4 FY2023, three months to 2023-12-31−$22.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-13, accession 0001558370-25-002904. Derived: 12-month figure less the 9-month figure.Report this figure(9.2)Net income, Q1 FY2024, three months to 2024-03-31−$9.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure(23.9)Net income, Q2 FY2024, three months to 2024-06-30−$23.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure(6.7)Net income, Q3 FY2024, three months to 2024-09-30−$6.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure(7.2)Net income, Q4 FY2024, three months to 2024-12-31−$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure(63.8)Net income, Q1 FY2025, three months to 2025-03-31−$63.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure(7.4)Net income, Q2 FY2025, three months to 2025-06-30−$7.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure(6.1)Net income, Q3 FY2025, three months to 2025-09-30−$6.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure(4.5)Net income, Q4 FY2025, three months to 2025-12-31−$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure(4.5)Net income, Q1 FY2026, three months to 2026-03-31−$4.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure(3.8)Net income, Q2 FY2026, three months to 2026-06-30−$3.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Diluted EPS$ per share0.00Diluted EPS, Q3 FY2023, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figurenot reported(0.01)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure(0.02)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure(0.01)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figurenot reported(0.07)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure(0.01)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure(0.01)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figurenot reported0.00Diluted EPS, Q1 FY2026, three months to 2026-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figurenot reported
Basic EPS$ per share0.00Basic EPS, Q3 FY2023, three months to 2023-09-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figurenot reported(0.01)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure(0.02)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.02 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure(0.01)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figurenot reported(0.07)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure(0.01)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure(0.01)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.01 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figurenot reported0.00Basic EPS, Q1 FY2026, three months to 2026-03-31$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure0.00Basic EPS, Q2 FY2026, three months to 2026-06-30$0.00 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure

Balance sheet

Cash and equivalents$7.2m, Q2 FY2026
Shareholders' equity$107.3m, Q2 FY2026
Zomedica Corp., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m21.8Cash and equivalents, Q3 FY2023, at 2023-09-30$21.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-11-13, accession 0001558370-23-018830.Report this figure13.0Cash and equivalents, FY2023, at 2023-12-31$13.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-13, accession 0001558370-25-002904.Report this figure10.9Cash and equivalents, Q1 FY2024, at 2024-03-31$10.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-09, accession 0001558370-24-007597.Report this figure7.9Cash and equivalents, Q2 FY2024, at 2024-06-30$7.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-14, accession 0001558370-24-012228.Report this figure9.7Cash and equivalents, Q3 FY2024, at 2024-09-30$9.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure7.0Cash and equivalents, FY2024, at 2024-12-31$7.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-16, accession 0001104659-26-028450.Report this figure8.8Cash and equivalents, Q1 FY2025, at 2025-03-31$8.8m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure8.1Cash and equivalents, Q2 FY2025, at 2025-06-30$8.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure7.5Cash and equivalents, Q3 FY2025, at 2025-09-30$7.5m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure9.0Cash and equivalents, FY2025, at 2025-12-31$9.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure9.4Cash and equivalents, Q1 FY2026, at 2026-03-31$9.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure7.2Cash and equivalents, Q2 FY2026, at 2026-06-30$7.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Current assets$m115Current assets, Q3 FY2023, at 2023-09-30$115.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018830.Report this figure99.9Current assets, FY2023, at 2023-12-31$99.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-13, accession 0001558370-25-002904.Report this figure92.1Current assets, Q1 FY2024, at 2024-03-31$92.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007597.Report this figure89.2Current assets, Q2 FY2024, at 2024-06-30$89.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-14, accession 0001558370-24-012228.Report this figure87.3Current assets, Q3 FY2024, at 2024-09-30$87.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure81.8Current assets, FY2024, at 2024-12-31$81.8m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-16, accession 0001104659-26-028450.Report this figure73.2Current assets, Q1 FY2025, at 2025-03-31$73.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure68.6Current assets, Q2 FY2025, at 2025-06-30$68.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure64.7Current assets, Q3 FY2025, at 2025-09-30$64.7m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure64.0Current assets, FY2025, at 2025-12-31$64.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure60.0Current assets, Q1 FY2026, at 2026-03-31$60.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure57.9Current assets, Q2 FY2026, at 2026-06-30$57.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Total assets$m275Total assets, Q3 FY2023, at 2023-09-30$275.1m. XBRL concept us-gaap:Assets. 10-Q filed 2023-11-13, accession 0001558370-23-018830.Report this figure253Total assets, FY2023, at 2023-12-31$253.2m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-13, accession 0001558370-25-002904.Report this figure244Total assets, Q1 FY2024, at 2024-03-31$243.7m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-09, accession 0001558370-24-007597.Report this figure220Total assets, Q2 FY2024, at 2024-06-30$219.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-14, accession 0001558370-24-012228.Report this figure214Total assets, Q3 FY2024, at 2024-09-30$214.1m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure207Total assets, FY2024, at 2024-12-31$207.4m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-16, accession 0001104659-26-028450.Report this figure143Total assets, Q1 FY2025, at 2025-03-31$143.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure136Total assets, Q2 FY2025, at 2025-06-30$136.5m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure131Total assets, Q3 FY2025, at 2025-09-30$130.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure127Total assets, FY2025, at 2025-12-31$127.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure122Total assets, Q1 FY2026, at 2026-03-31$121.5m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure118Total assets, Q2 FY2026, at 2026-06-30$118.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Current liabilities$m6.7Current liabilities, Q3 FY2023, at 2023-09-30$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-11-13, accession 0001558370-23-018830.Report this figure9.0Current liabilities, FY2023, at 2023-12-31$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-13, accession 0001558370-25-002904.Report this figure8.0Current liabilities, Q1 FY2024, at 2024-03-31$8.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-09, accession 0001558370-24-007597.Report this figure7.8Current liabilities, Q2 FY2024, at 2024-06-30$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-14, accession 0001558370-24-012228.Report this figure8.1Current liabilities, Q3 FY2024, at 2024-09-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure9.3Current liabilities, FY2024, at 2024-12-31$9.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-16, accession 0001104659-26-028450.Report this figure7.4Current liabilities, Q1 FY2025, at 2025-03-31$7.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure8.1Current liabilities, Q2 FY2025, at 2025-06-30$8.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure8.4Current liabilities, Q3 FY2025, at 2025-09-30$8.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure9.4Current liabilities, FY2025, at 2025-12-31$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure8.6Current liabilities, Q1 FY2026, at 2026-03-31$8.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure9.0Current liabilities, Q2 FY2026, at 2026-06-30$9.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Total liabilities$m14.2Total liabilities, Q3 FY2023, at 2023-09-30$14.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-11-13, accession 0001558370-23-018830.Report this figure13.2Total liabilities, FY2023, at 2023-12-31$13.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-13, accession 0001558370-25-002904.Report this figure11.8Total liabilities, Q1 FY2024, at 2024-03-31$11.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-09, accession 0001558370-24-007597.Report this figure11.2Total liabilities, Q2 FY2024, at 2024-06-30$11.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-14, accession 0001558370-24-012228.Report this figure11.3Total liabilities, Q3 FY2024, at 2024-09-30$11.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure11.7Total liabilities, FY2024, at 2024-12-31$11.7m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-16, accession 0001104659-26-028450.Report this figure10.5Total liabilities, Q1 FY2025, at 2025-03-31$10.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure11.1Total liabilities, Q2 FY2025, at 2025-06-30$11.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure11.2Total liabilities, Q3 FY2025, at 2025-09-30$11.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure11.6Total liabilities, FY2025, at 2025-12-31$11.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure10.6Total liabilities, Q1 FY2026, at 2026-03-31$10.6m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure10.9Total liabilities, Q2 FY2026, at 2026-06-30$10.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Current portion of debt$mnot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reportednot reported
Shareholders' equity$m261Shareholders' equity, Q3 FY2023, at 2023-09-30$260.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure240Shareholders' equity, FY2023, at 2023-12-31$240.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-16, accession 0001104659-26-028450.Report this figure232Shareholders' equity, Q1 FY2024, at 2024-03-31$231.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure209Shareholders' equity, Q2 FY2024, at 2024-06-30$208.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure203Shareholders' equity, Q3 FY2024, at 2024-09-30$202.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure196Shareholders' equity, FY2024, at 2024-12-31$195.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure132Shareholders' equity, Q1 FY2025, at 2025-03-31$132.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure125Shareholders' equity, Q2 FY2025, at 2025-06-30$125.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure120Shareholders' equity, Q3 FY2025, at 2025-09-30$119.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure115Shareholders' equity, FY2025, at 2025-12-31$115.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure111Shareholders' equity, Q1 FY2026, at 2026-03-31$110.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure107Shareholders' equity, Q2 FY2026, at 2026-06-30$107.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure

Cash flow

Operating cash flow−$2.6m, Q2 FY2026
Capital expenditure$92.0k, Q2 FY2026
Zomedica Corp., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(3,027)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$3.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-07, accession 0001558370-24-014859. Derived: 9-month figure less the 6-month figure.Report this figure(5,015)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$5.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-13, accession 0001558370-25-002904. Derived: 12-month figure less the 9-month figure.Report this figure(7,590)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$7.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure(6,719)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$6.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-06, accession 0001558370-25-010512. Derived: 6-month figure less the 3-month figure.Report this figure(4,796)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$4.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001104659-25-106266. Derived: 9-month figure less the 6-month figure.Report this figure(4,525)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$4.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure(6,648)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure(5,442)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$5.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001104659-26-091075. Derived: 6-month figure less the 3-month figure.Report this figure(4,660)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$4.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001104659-25-106266. Derived: 9-month figure less the 6-month figure.Report this figure(899)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$899.0k. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure(5,257)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$5.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure(2,551)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$2.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001104659-26-091075. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$k6,471Capital expenditure, Q3 FY2023, three months to 2023-09-30$6.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-07, accession 0001558370-24-014859. Derived: 9-month figure less the 6-month figure.Report this figure2,035Capital expenditure, Q4 FY2023, three months to 2023-12-31$2.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-13, accession 0001558370-25-002904. Derived: 12-month figure less the 9-month figure.Report this figure2,335Capital expenditure, Q1 FY2024, three months to 2024-03-31$2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure1,224Capital expenditure, Q2 FY2024, three months to 2024-06-30$1.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-08-06, accession 0001558370-25-010512. Derived: 6-month figure less the 3-month figure.Report this figure1,078Capital expenditure, Q3 FY2024, three months to 2024-09-30$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001104659-25-106266. Derived: 9-month figure less the 6-month figure.Report this figure575Capital expenditure, Q4 FY2024, three months to 2024-12-31$575.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure280Capital expenditure, Q1 FY2025, three months to 2025-03-31$280.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure137Capital expenditure, Q2 FY2025, three months to 2025-06-30$137.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001104659-26-091075. Derived: 6-month figure less the 3-month figure.Report this figure43.0Capital expenditure, Q3 FY2025, three months to 2025-09-30$43.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001104659-25-106266. Derived: 9-month figure less the 6-month figure.Report this figure107Capital expenditure, Q4 FY2025, three months to 2025-12-31$107.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-16, accession 0001104659-26-028450. Derived: 12-month figure less the 9-month figure.Report this figure60.0Capital expenditure, Q1 FY2026, three months to 2026-03-31$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001104659-26-056236.Report this figure92.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$92.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001104659-26-091075. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)979.95m, Q3 FY2025
Zomedica Corp., shares, quarterly
Line itemUnitQ1 FY20222022-03-31Q2 FY20222022-06-30Q3 FY20222022-09-30Q1 FY20232023-03-31Q2 FY20232023-06-30Q3 FY20232023-09-30Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30
Diluted shares (weighted)m shares980Diluted shares (weighted), Q1 FY2022, three months to 2022-03-31979,899,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-05-11, accession 0001558370-23-009389.Report this figure980Diluted shares (weighted), Q2 FY2022, three months to 2022-06-30979,899,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-08-10, accession 0001558370-23-014491.Report this figure980Diluted shares (weighted), Q3 FY2022, three months to 2022-09-30979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2023-11-13, accession 0001558370-23-018830.Report this figure980Diluted shares (weighted), Q1 FY2023, three months to 2023-03-31979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-05-09, accession 0001558370-24-007597.Report this figure980Diluted shares (weighted), Q2 FY2023, three months to 2023-06-30979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-08-14, accession 0001558370-24-012228.Report this figure980Diluted shares (weighted), Q3 FY2023, three months to 2023-09-30979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2024-11-07, accession 0001558370-24-014859.Report this figure980Diluted shares (weighted), Q1 FY2024, three months to 2024-03-31979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure980Diluted shares (weighted), Q2 FY2024, three months to 2024-06-30979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure980Diluted shares (weighted), Q3 FY2024, three months to 2024-09-30979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure980Diluted shares (weighted), Q1 FY2025, three months to 2025-03-31979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-15, accession 0001558370-25-007874.Report this figure980Diluted shares (weighted), Q2 FY2025, three months to 2025-06-30979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-06, accession 0001558370-25-010512.Report this figure980Diluted shares (weighted), Q3 FY2025, three months to 2025-09-30979,949,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-04, accession 0001104659-25-106266.Report this figure

Shares outstanding: 979.95mShares outstanding, period not labelled, at 2026-08-05979,949,668 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-05, accession 0001104659-26-091075.Report this figure at Aug 5, 2026, from the cover of the 10-Q filed Aug 5, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. Listed shows no prices and gives no investment advice.